Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

Item

http://www.wikidata.org/entity/Q27319831

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice

@nl

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@ast

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@en

type

Item

label

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice

@nl

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@ast

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@en

prefLabel

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice

@nl

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@ast

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.

@en

P1476

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice

@en

P2093

Ann Marie Schmidt

http://www.w3.org/2001/XMLSchema#string

Benjamin J Kaplan

http://www.w3.org/2001/XMLSchema#string

Gurdip K Daffu

http://www.w3.org/2001/XMLSchema#string

Lauren Kelly

http://www.w3.org/2001/XMLSchema#string

Matthew S Geddis

http://www.w3.org/2001/XMLSchema#string

Rosa Rosario

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

A practical guide to understanding Kaplan-Meier curves

Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice

The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease.

Effect of TTP488 in patients with mild to moderate Alzheimer's disease.

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.

P304

117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1774391

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FNCEL.2016.00117

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Judyta Juranek

Huilin Li

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27242430

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4860390

http://www.w3.org/2001/XMLSchema#string